USANA Health Sciences Inc (USNA) — Analysis Summary
USANA Health Sciences Inc (USNA) has a market cap of $276.22M with year-over-year revenue growth of +8.3%. Net margin stands at 1.2%. The stock trades at a P/E ratio of -12.5.
Key Takeaways
- Revenue changed +8.3% year-over-year
- Net margin of 1.2%
- P/E ratio of -12.5
Compared to other companies in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector, USNA posted revenue growth of +8.3% and trades at a P/E of -12.5.
USANA Health Sciences Inc (USNA)
PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Interest coverage at -2.6x — earnings do not cover interest payments
Net income turned negative after a profitable prior period.
Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).
Sector
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Employees
1,570
Headquarters
SALT LAKE CITY, UT
Exchange
XNYS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.